RxDoctor Payments Data

Cheyenne Trammell

Physician Assistant · Batavia, OHNPI 1295318822

Payments from drug & device makers

$2,115in general payments, 2019–2025

Across 72 payments — averaging $29.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inspire Medical Systems, Inc.$1K
  • GSK$318
  • Sanofi$167
  • Actelion Pharmaceuticals US, Inc.$123
  • Pulmonx Corporation$63
  • Baxter Healthcare$42
  • plus $157 from 5 others

What the payments were for

  • Travel & lodging$60529%
  • Food & beverage$1,51071%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,115 in reported general payments places this provider in the 85th percentile of 4,098 physician assistant providers in Ohio.

See all physician assistant providers in Ohio

Medicare billing

Part B allowed, 2024
$16,047
Medicare patients
115
Services billed
178

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter354$320,715
Dupixent PenDupilumab34$138,566
Breztri AerosphereBudesonide/Glycopyr/Formoterol66$47,721
Spiriva RespimatTiotropium Bromide37$22,763
Stiolto RespimatTiotropium Br/Olodaterol Hcl28$18,852
SymbicortBudesonide/Formoterol Fumarate36$11,654
Combivent RespimatIpratropium/Albuterol Sulfate12$11,540
Albuterol Sulfate HfaAlbuterol Sulfate323$10,758
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr19$10,572
Breo ElliptaFluticasone/Vilanterol16$8,712
Advair HfaFluticasone Propion/Salmeterol15$8,338
Incruse ElliptaUmeclidinium Bromide11$6,705
Fluticasone-SalmeterolFluticasone Propion/Salmeterol40$6,658
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate17$4,083
Ventolin HfaAlbuterol Sulfate37$2,421

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta, Incruse Ellipta$318$346,704400 claims
Boehringer IngelheimSpiriva Respimat, Stiolto Respimat, Combivent Respimat$39$53,15677 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,098 physician assistant providers in Ohio.

Other physician assistant in Batavia

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →